Items Tagged ‘SSRI’

June 10, 2019

Meet William Bobo, M.D. – taking the guesswork out of finding the right depression therapy

By Sharon Rosen sharonhrosen

Depression can touch every aspect of a person’s life – affecting the way they think, feel and behave. It is also the leading medical condition for those who complete suicide. Getting the right therapy is crucial. But for patients suffering from the disorder, finding an effective treatment often involves trial and error. That’s because it […]

View full entry

Tags: #Artificial Intelligence, #Center for Individualized Mediicine, #Dr. Arjun Athreya, #Dr. William Bobo, #individualized mediicne, #Mayo Clinic and Illinois Alliance for Technology-Based Healthcare, #mood disorders, #predictive algorithm, #selective serotonin reuptake inhibitors, #targeted therapies, #Treatment response, antidepressants


Genome-Wide Associations of Citalopram and Escitalopram Plasma Drug and Metabolite Concentrations

July 15, 2014

Genome-Wide Associations of Citalopram and Escitalopram Plasma Drug and Metabolite Concentrations

By Center for Individualized Medicine samuelsmith5209

    Published in the British Journal of Clinical Pharmacology, a team of researchers from the Mayo Clinic, led by the director of the Center for Individualized Medicine’s Pharmacogenomics Program, Richard Weinshilboum, M.D., applied a genome-wide association study (GWAS) to identify genetic factors that contribute to variation in plasma concentrations of Citalopram (CT) or escitalopram (S-CT), and […]

View full entry

Tags: center for individualized medicine, citalopram, DNA, DNA Sequencing, dna test, DNA Testing, escitalopram, gene sequencing, genetic, Genetics, genome, genome science


March 13, 2014

Citalopram and Escitalopram Plasma Drug and Metabolite Concentrations: Genome-Wide Associations

By

A recently published article in the area of Pharmacogenomics set out to identify genetic factors in Citalopram (CT) and escitalopram (S-CT), which are among the most widely prescribed serotonin reuptake inhibitors (SSRIs) used to treat Major Depressive Disorder (MDD), that contribute to variation in plasma concentrations of CT or S-CT and their metabolites in MDD patients treated […]

View full entry

Tags: citalopram, dna test, DNA Testing, escitalopram, gene sequencing, genome science, genome-wide association studies, genomic medicine, genomics, individualized medicine, major depressive disorder, personal genomics


Contact Us · Privacy Policy